The global Meningococcal Vaccine market is projected to grow from US$ 274.5 million in 2024 to US$ 355.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.

Meningococcal Vaccine Market

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.

Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.

In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.

Report Covers:

This report presents an overview of global market for Meningococcal Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Meningococcal Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Meningococcal Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Meningococcal Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Meningococcal Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Meningococcal Vaccine sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Meningococcal Vaccine Market Report

Report Metric	Details
Report Name	Meningococcal Vaccine Market
Accounted market size in 2024	US$ 274.5 million
Forecasted market size in 2030	US$ 355.4 million
CAGR	4.4
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Meningtits A Polysaccharide Meningtitis AC Meningitis ACYW
Segment by Application	6 Months-15Year over 3 Year over 2 Year over 3 Months
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Walvax, Zhifei
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Meningococcal Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Meningococcal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Meningococcal Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Meningococcal Vaccine Market growing?

Ans: The Meningococcal Vaccine Market witnessing a CAGR of 4.4 during the forecast period 2024-2030.

What is the Meningococcal Vaccine Market size in 2030?

Ans: The Meningococcal Vaccine Market size in 2030 will be US$ 355.4 million.

What is the market share of major companies in Meningococcal Vaccine Market?

Ans: Global top five players hold a share about 80%.

What is the Meningococcal Vaccine Market share by type?

Ans: In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%.

Who are the main players in the Meningococcal Vaccine Market report?

Ans: The main players in the Meningococcal Vaccine Market are Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Walvax, Zhifei

What are the Application segmentation covered in the Meningococcal Vaccine Market report?

Ans: The Applications covered in the Meningococcal Vaccine Market report are 6 Months-15Year, over 3 Year, over 2 Year, over 3 Months

What are the Type segmentation covered in the Meningococcal Vaccine Market report?

Ans: The Types covered in the Meningococcal Vaccine Market report are Meningtits A, Polysaccharide Meningtitis AC, Meningitis ACYW

1 Study Coverage

1.1 Meningococcal Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Meningococcal Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Meningtits A

1.2.3 Polysaccharide Meningtitis AC

1.2.4 Meningitis ACYW

1.3 Market by Application

1.3.1 Global Meningococcal Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 6 Months-15Year

1.3.3 over 3 Year

1.3.4 over 2 Year

1.3.5 over 3 Months

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Meningococcal Vaccine Sales Estimates and Forecasts 2019-2030

2.2 Global Meningococcal Vaccine Revenue by Region

2.2.1 Global Meningococcal Vaccine Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Meningococcal Vaccine Revenue by Region (2019-2024)

2.2.3 Global Meningococcal Vaccine Revenue by Region (2025-2030)

2.2.4 Global Meningococcal Vaccine Revenue Market Share by Region (2019-2030)

2.3 Global Meningococcal Vaccine Sales Estimates and Forecasts 2019-2030

2.4 Global Meningococcal Vaccine Sales by Region

2.4.1 Global Meningococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Meningococcal Vaccine Sales by Region (2019-2024)

2.4.3 Global Meningococcal Vaccine Sales by Region (2025-2030)

2.4.4 Global Meningococcal Vaccine Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Meningococcal Vaccine Sales by Manufacturers

3.1.1 Global Meningococcal Vaccine Sales by Manufacturers (2019-2024)

3.1.2 Global Meningococcal Vaccine Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Meningococcal Vaccine in 2023

3.2 Global Meningococcal Vaccine Revenue by Manufacturers

3.2.1 Global Meningococcal Vaccine Revenue by Manufacturers (2019-2024)

3.2.2 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Meningococcal Vaccine Revenue in 2023

3.3 Global Key Players of Meningococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Meningococcal Vaccine Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Meningococcal Vaccine, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Meningococcal Vaccine, Product Offered and Application

3.8 Global Key Manufacturers of Meningococcal Vaccine, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Meningococcal Vaccine Sales by Type

4.1.1 Global Meningococcal Vaccine Historical Sales by Type (2019-2024)

4.1.2 Global Meningococcal Vaccine Forecasted Sales by Type (2025-2030)

4.1.3 Global Meningococcal Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Meningococcal Vaccine Revenue by Type

4.2.1 Global Meningococcal Vaccine Historical Revenue by Type (2019-2024)

4.2.2 Global Meningococcal Vaccine Forecasted Revenue by Type (2025-2030)

4.2.3 Global Meningococcal Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Meningococcal Vaccine Price by Type

4.3.1 Global Meningococcal Vaccine Price by Type (2019-2024)

4.3.2 Global Meningococcal Vaccine Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Meningococcal Vaccine Sales by Application

5.1.1 Global Meningococcal Vaccine Historical Sales by Application (2019-2024)

5.1.2 Global Meningococcal Vaccine Forecasted Sales by Application (2025-2030)

5.1.3 Global Meningococcal Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Meningococcal Vaccine Revenue by Application

5.2.1 Global Meningococcal Vaccine Historical Revenue by Application (2019-2024)

5.2.2 Global Meningococcal Vaccine Forecasted Revenue by Application (2025-2030)

5.2.3 Global Meningococcal Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Meningococcal Vaccine Price by Application

5.3.1 Global Meningococcal Vaccine Price by Application (2019-2024)

5.3.2 Global Meningococcal Vaccine Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Meningococcal Vaccine Market Size by Type

6.1.1 US & Canada Meningococcal Vaccine Sales by Type (2019-2030)

6.1.2 US & Canada Meningococcal Vaccine Revenue by Type (2019-2030)

6.2 US & Canada Meningococcal Vaccine Market Size by Application

6.2.1 US & Canada Meningococcal Vaccine Sales by Application (2019-2030)

6.2.2 US & Canada Meningococcal Vaccine Revenue by Application (2019-2030)

6.3 US & Canada Meningococcal Vaccine Market Size by Country

6.3.1 US & Canada Meningococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Meningococcal Vaccine Sales by Country (2019-2030)

6.3.3 US & Canada Meningococcal Vaccine Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Meningococcal Vaccine Market Size by Type

7.1.1 Europe Meningococcal Vaccine Sales by Type (2019-2030)

7.1.2 Europe Meningococcal Vaccine Revenue by Type (2019-2030)

7.2 Europe Meningococcal Vaccine Market Size by Application

7.2.1 Europe Meningococcal Vaccine Sales by Application (2019-2030)

7.2.2 Europe Meningococcal Vaccine Revenue by Application (2019-2030)

7.3 Europe Meningococcal Vaccine Market Size by Country

7.3.1 Europe Meningococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Meningococcal Vaccine Sales by Country (2019-2030)

7.3.3 Europe Meningococcal Vaccine Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Meningococcal Vaccine Market Size

8.1.1 China Meningococcal Vaccine Sales (2019-2030)

8.1.2 China Meningococcal Vaccine Revenue (2019-2030)

8.2 China Meningococcal Vaccine Market Size by Application

8.2.1 China Meningococcal Vaccine Sales by Application (2019-2030)

8.2.2 China Meningococcal Vaccine Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Meningococcal Vaccine Market Size by Type

9.1.1 Asia Meningococcal Vaccine Sales by Type (2019-2030)

9.1.2 Asia Meningococcal Vaccine Revenue by Type (2019-2030)

9.2 Asia Meningococcal Vaccine Market Size by Application

9.2.1 Asia Meningococcal Vaccine Sales by Application (2019-2030)

9.2.2 Asia Meningococcal Vaccine Revenue by Application (2019-2030)

9.3 Asia Meningococcal Vaccine Sales by Region

9.3.1 Asia Meningococcal Vaccine Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Meningococcal Vaccine Revenue by Region (2019-2030)

9.3.3 Asia Meningococcal Vaccine Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Meningococcal Vaccine Market Size by Type

10.1.1 Middle East, Africa and Latin America Meningococcal Vaccine Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Meningococcal Vaccine Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Meningococcal Vaccine Market Size by Application

10.2.1 Middle East, Africa and Latin America Meningococcal Vaccine Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Meningococcal Vaccine Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Meningococcal Vaccine Sales by Country

10.3.1 Middle East, Africa and Latin America Meningococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Meningococcal Vaccine Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Meningococcal Vaccine Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Novartis

11.1.1 Novartis Company Information

11.1.2 Novartis Overview

11.1.3 Novartis Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Novartis Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Novartis Recent Developments

11.2 GSK

11.2.1 GSK Company Information

11.2.2 GSK Overview

11.2.3 GSK Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 GSK Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 GSK Recent Developments

11.3 Merck

11.3.1 Merck Company Information

11.3.2 Merck Overview

11.3.3 Merck Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Merck Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Merck Recent Developments

11.4 CSL

11.4.1 CSL Company Information

11.4.2 CSL Overview

11.4.3 CSL Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 CSL Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 CSL Recent Developments

11.5 Baxter

11.5.1 Baxter Company Information

11.5.2 Baxter Overview

11.5.3 Baxter Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Baxter Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Baxter Recent Developments

11.6 JN International Medical Corporation

11.6.1 JN International Medical Corporation Company Information

11.6.2 JN International Medical Corporation Overview

11.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 JN International Medical Corporation Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 JN International Medical Corporation Recent Developments

11.7 Serum Institute of India

11.7.1 Serum Institute of India Company Information

11.7.2 Serum Institute of India Overview

11.7.3 Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Serum Institute of India Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Serum Institute of India Recent Developments

11.8 Bio-Med

11.8.1 Bio-Med Company Information

11.8.2 Bio-Med Overview

11.8.3 Bio-Med Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Bio-Med Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Bio-Med Recent Developments

11.9 China National Biotec Group

11.9.1 China National Biotec Group Company Information

11.9.2 China National Biotec Group Overview

11.9.3 China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 China National Biotec Group Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 China National Biotec Group Recent Developments

11.10 Hualan Bio

11.10.1 Hualan Bio Company Information

11.10.2 Hualan Bio Overview

11.10.3 Hualan Bio Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Hualan Bio Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Hualan Bio Recent Developments

11.11 Walvax

11.11.1 Walvax Company Information

11.11.2 Walvax Overview

11.11.3 Walvax Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 Walvax Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Walvax Recent Developments

11.12 Zhifei

11.12.1 Zhifei Company Information

11.12.2 Zhifei Overview

11.12.3 Zhifei Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 Zhifei Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Zhifei Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Meningococcal Vaccine Industry Chain Analysis

12.2 Meningococcal Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Meningococcal Vaccine Production Mode & Process

12.4 Meningococcal Vaccine Sales and Marketing

12.4.1 Meningococcal Vaccine Sales Channels

12.4.2 Meningococcal Vaccine Distributors

12.5 Meningococcal Vaccine Customers

13 Market Dynamics

13.1 Meningococcal Vaccine Industry Trends

13.2 Meningococcal Vaccine Market Drivers

13.3 Meningococcal Vaccine Market Challenges

13.4 Meningococcal Vaccine Market Restraints

14 Key Findings in The Global Meningococcal Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

JN International Medical Corporation

Serum Institute of India

China National Biotec Group

List of Tables

Table 1. Global Meningococcal Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Meningtits A

Table 3. Major Manufacturers of Polysaccharide Meningtitis AC

Table 4. Major Manufacturers of Meningitis ACYW

Table 5. Global Meningococcal Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Meningococcal Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Meningococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Meningococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Meningococcal Vaccine Revenue Market Share by Region (2019-2024)

Table 10. Global Meningococcal Vaccine Revenue Market Share by Region (2025-2030)

Table 11. Global Meningococcal Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global Meningococcal Vaccine Sales by Region (2019-2024) & (10K Pcs)

Table 13. Global Meningococcal Vaccine Sales by Region (2025-2030) & (10K Pcs)

Table 14. Global Meningococcal Vaccine Sales Market Share by Region (2019-2024)

Table 15. Global Meningococcal Vaccine Sales Market Share by Region (2025-2030)

Table 16. Global Meningococcal Vaccine Sales by Manufacturers (2019-2024) & (10K Pcs)

Table 17. Global Meningococcal Vaccine Sales Share by Manufacturers (2019-2024)

Table 18. Global Meningococcal Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Meningococcal Vaccine Revenue Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Meningococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 21. Meningococcal Vaccine Price by Manufacturers 2019-2024 (USD/Pcs)

Table 22. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2023)

Table 24. Global Key Manufacturers of Meningococcal Vaccine, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Meningococcal Vaccine, Product Offered and Application

Table 26. Global Key Manufacturers of Meningococcal Vaccine, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)

Table 29. Global Meningococcal Vaccine Sales by Type (2025-2030) & (10K Pcs)

Table 30. Global Meningococcal Vaccine Sales Share by Type (2019-2024)

Table 31. Global Meningococcal Vaccine Sales Share by Type (2025-2030)

Table 32. Global Meningococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Meningococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Meningococcal Vaccine Revenue Share by Type (2019-2024)

Table 35. Global Meningococcal Vaccine Revenue Share by Type (2025-2030)

Table 36. Meningococcal Vaccine Price by Type (2019-2024) & (USD/Pcs)

Table 37. Global Meningococcal Vaccine Price Forecast by Type (2025-2030) & (USD/Pcs)

Table 38. Global Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)

Table 39. Global Meningococcal Vaccine Sales by Application (2025-2030) & (10K Pcs)

Table 40. Global Meningococcal Vaccine Sales Share by Application (2019-2024)

Table 41. Global Meningococcal Vaccine Sales Share by Application (2025-2030)

Table 42. Global Meningococcal Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Meningococcal Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Meningococcal Vaccine Revenue Share by Application (2019-2024)

Table 45. Global Meningococcal Vaccine Revenue Share by Application (2025-2030)

Table 46. Meningococcal Vaccine Price by Application (2019-2024) & (USD/Pcs)

Table 47. Global Meningococcal Vaccine Price Forecast by Application (2025-2030) & (USD/Pcs)

Table 48. US & Canada Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)

Table 49. US & Canada Meningococcal Vaccine Sales by Type (2025-2030) & (10K Pcs)

Table 50. US & Canada Meningococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Meningococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)

Table 53. US & Canada Meningococcal Vaccine Sales by Application (2025-2030) & (10K Pcs)

Table 54. US & Canada Meningococcal Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Meningococcal Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Meningococcal Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Meningococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Meningococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)

Table 60. US & Canada Meningococcal Vaccine Sales by Country (2025-2030) & (10K Pcs)

Table 61. Europe Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)

Table 62. Europe Meningococcal Vaccine Sales by Type (2025-2030) & (10K Pcs)

Table 63. Europe Meningococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Meningococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)

Table 66. Europe Meningococcal Vaccine Sales by Application (2025-2030) & (10K Pcs)

Table 67. Europe Meningococcal Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Meningococcal Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Meningococcal Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Meningococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Meningococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)

Table 73. Europe Meningococcal Vaccine Sales by Country (2025-2030) & (10K Pcs)

Table 74. China Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)

Table 75. China Meningococcal Vaccine Sales by Type (2025-2030) & (10K Pcs)

Table 76. China Meningococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Meningococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)

Table 79. China Meningococcal Vaccine Sales by Application (2025-2030) & (10K Pcs)

Table 80. China Meningococcal Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Meningococcal Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)

Table 83. Asia Meningococcal Vaccine Sales by Type (2025-2030) & (10K Pcs)

Table 84. Asia Meningococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Meningococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)

Table 87. Asia Meningococcal Vaccine Sales by Application (2025-2030) & (10K Pcs)

Table 88. Asia Meningococcal Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Meningococcal Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Meningococcal Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Meningococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Meningococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Meningococcal Vaccine Sales by Region (2019-2024) & (10K Pcs)

Table 94. Asia Meningococcal Vaccine Sales by Region (2025-2030) & (10K Pcs)

Table 95. Middle East, Africa and Latin America Meningococcal Vaccine Sales by Type (2019-2024) & (10K Pcs)

Table 96. Middle East, Africa and Latin America Meningococcal Vaccine Sales by Type (2025-2030) & (10K Pcs)

Table 97. Middle East, Africa and Latin America Meningococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Meningococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Meningococcal Vaccine Sales by Application (2019-2024) & (10K Pcs)

Table 100. Middle East, Africa and Latin America Meningococcal Vaccine Sales by Application (2025-2030) & (10K Pcs)

Table 101. Middle East, Africa and Latin America Meningococcal Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Meningococcal Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Meningococcal Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Meningococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Meningococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Meningococcal Vaccine Sales by Country (2019-2024) & (10K Pcs)

Table 107. Middle East, Africa and Latin America Meningococcal Vaccine Sales by Country (2025-2030) & (10K Pcs)

Table 108. Novartis Company Information

Table 109. Novartis Description and Major Businesses

Table 110. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 111. Novartis Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Novartis Recent Developments

Table 113. GSK Company Information

Table 114. GSK Description and Major Businesses

Table 115. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 116. GSK Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. GSK Recent Developments

Table 118. Merck Company Information

Table 119. Merck Description and Major Businesses

Table 120. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 121. Merck Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Merck Recent Developments

Table 123. CSL Company Information

Table 124. CSL Description and Major Businesses

Table 125. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 126. CSL Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. CSL Recent Developments

Table 128. Baxter Company Information

Table 129. Baxter Description and Major Businesses

Table 130. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 131. Baxter Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Baxter Recent Developments

Table 133. JN International Medical Corporation Company Information

Table 134. JN International Medical Corporation Description and Major Businesses

Table 135. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 136. JN International Medical Corporation Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. JN International Medical Corporation Recent Developments

Table 138. Serum Institute of India Company Information

Table 139. Serum Institute of India Description and Major Businesses

Table 140. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 141. Serum Institute of India Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Serum Institute of India Recent Developments

Table 143. Bio-Med Company Information

Table 144. Bio-Med Description and Major Businesses

Table 145. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 146. Bio-Med Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. Bio-Med Recent Developments

Table 148. China National Biotec Group Company Information

Table 149. China National Biotec Group Description and Major Businesses

Table 150. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 151. China National Biotec Group Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. China National Biotec Group Recent Developments

Table 153. Hualan Bio Company Information

Table 154. Hualan Bio Description and Major Businesses

Table 155. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 156. Hualan Bio Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Hualan Bio Recent Developments

Table 158. Walvax Company Information

Table 159. Walvax Description and Major Businesses

Table 160. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 161. Walvax Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. Walvax Recent Developments

Table 163. Zhifei Company Information

Table 164. Zhifei Description and Major Businesses

Table 165. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 166. Zhifei Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 167. Zhifei Recent Developments

Table 168. Key Raw Materials Lists

Table 169. Raw Materials Key Suppliers Lists

Table 170. Meningococcal Vaccine Distributors List

Table 171. Meningococcal Vaccine Customers List

Table 172. Meningococcal Vaccine Market Trends

Table 173. Meningococcal Vaccine Market Drivers

Table 174. Meningococcal Vaccine Market Challenges

Table 175. Meningococcal Vaccine Market Restraints

Table 176. Research Programs/Design for This Report

Table 177. Key Data Information from Secondary Sources

Table 178. Key Data Information from Primary Sources

List of Figures

Figure 1. Meningococcal Vaccine Product Picture

Figure 2. Global Meningococcal Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Meningococcal Vaccine Market Share by Type in 2023 & 2030

Figure 4. Meningtits A Product Picture

Figure 5. Polysaccharide Meningtitis AC Product Picture

Figure 6. Meningitis ACYW Product Picture

Figure 7. Global Meningococcal Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Meningococcal Vaccine Market Share by Application in 2023 & 2030

Figure 9. 6 Months-15Year

Figure 10. over 3 Year

Figure 11. over 2 Year

Figure 12. over 3 Months

Figure 13. Meningococcal Vaccine Report Years Considered

Figure 14. Global Meningococcal Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Meningococcal Vaccine Revenue 2019-2030 (US$ Million)

Figure 16. Global Meningococcal Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 17. Global Meningococcal Vaccine Revenue Market Share by Region (2019-2030)

Figure 18. Global Meningococcal Vaccine Sales 2019-2030 ((10K Pcs)

Figure 19. Global Meningococcal Vaccine Sales Market Share by Region (2019-2030)

Figure 20. US & Canada Meningococcal Vaccine Sales YoY (2019-2030) & (10K Pcs)

Figure 21. US & Canada Meningococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 22. Europe Meningococcal Vaccine Sales YoY (2019-2030) & (10K Pcs)

Figure 23. Europe Meningococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 24. China Meningococcal Vaccine Sales YoY (2019-2030) & (10K Pcs)

Figure 25. China Meningococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Asia (excluding China) Meningococcal Vaccine Sales YoY (2019-2030) & (10K Pcs)

Figure 27. Asia (excluding China) Meningococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Meningococcal Vaccine Sales YoY (2019-2030) & (10K Pcs)

Figure 29. Middle East, Africa and Latin America Meningococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 30. The Meningococcal Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 31. The Top 5 and 10 Largest Manufacturers of Meningococcal Vaccine in the World: Market Share by Meningococcal Vaccine Revenue in 2023

Figure 32. Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 33. Global Meningococcal Vaccine Sales Market Share by Type (2019-2030)

Figure 34. Global Meningococcal Vaccine Revenue Market Share by Type (2019-2030)

Figure 35. Global Meningococcal Vaccine Sales Market Share by Application (2019-2030)

Figure 36. Global Meningococcal Vaccine Revenue Market Share by Application (2019-2030)

Figure 37. US & Canada Meningococcal Vaccine Sales Market Share by Type (2019-2030)

Figure 38. US & Canada Meningococcal Vaccine Revenue Market Share by Type (2019-2030)

Figure 39. US & Canada Meningococcal Vaccine Sales Market Share by Application (2019-2030)

Figure 40. US & Canada Meningococcal Vaccine Revenue Market Share by Application (2019-2030)

Figure 41. US & Canada Meningococcal Vaccine Revenue Share by Country (2019-2030)

Figure 42. US & Canada Meningococcal Vaccine Sales Share by Country (2019-2030)

Figure 43. U.S. Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 44. Canada Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 45. Europe Meningococcal Vaccine Sales Market Share by Type (2019-2030)

Figure 46. Europe Meningococcal Vaccine Revenue Market Share by Type (2019-2030)

Figure 47. Europe Meningococcal Vaccine Sales Market Share by Application (2019-2030)

Figure 48. Europe Meningococcal Vaccine Revenue Market Share by Application (2019-2030)

Figure 49. Europe Meningococcal Vaccine Revenue Share by Country (2019-2030)

Figure 50. Europe Meningococcal Vaccine Sales Share by Country (2019-2030)

Figure 51. Germany Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 52. France Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 53. U.K. Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 54. Italy Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 55. Russia Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 56. China Meningococcal Vaccine Sales Market Share by Type (2019-2030)

Figure 57. China Meningococcal Vaccine Revenue Market Share by Type (2019-2030)

Figure 58. China Meningococcal Vaccine Sales Market Share by Application (2019-2030)

Figure 59. China Meningococcal Vaccine Revenue Market Share by Application (2019-2030)

Figure 60. Asia Meningococcal Vaccine Sales Market Share by Type (2019-2030)

Figure 61. Asia Meningococcal Vaccine Revenue Market Share by Type (2019-2030)

Figure 62. Asia Meningococcal Vaccine Sales Market Share by Application (2019-2030)

Figure 63. Asia Meningococcal Vaccine Revenue Market Share by Application (2019-2030)

Figure 64. Asia Meningococcal Vaccine Revenue Share by Region (2019-2030)

Figure 65. Asia Meningococcal Vaccine Sales Share by Region (2019-2030)

Figure 66. Japan Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 67. South Korea Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 68. China Taiwan Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 69. Southeast Asia Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 70. India Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 71. Middle East, Africa and Latin America Meningococcal Vaccine Sales Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Meningococcal Vaccine Revenue Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Meningococcal Vaccine Sales Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Meningococcal Vaccine Revenue Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Meningococcal Vaccine Revenue Share by Country (2019-2030)

Figure 76. Middle East, Africa and Latin America Meningococcal Vaccine Sales Share by Country (2019-2030)

Figure 77. Brazil Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 78. Mexico Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 79. Turkey Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 80. Israel Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 81. GCC Countries Meningococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 82. Meningococcal Vaccine Value Chain

Figure 83. Meningococcal Vaccine Production Process

Figure 84. Channels of Distribution

Figure 85. Distributors Profiles

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions